Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The DoloTest® in a specialized headache center among patients receiving psychological treatment. A pilot study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Chronic pain after bilateral thoracotomy in lung transplant patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

    Research output: Contribution to journalReviewResearchpeer-review

  1. Episodic and Chronic Cluster Headache: Differences in Family History, Traumatic Head Injury, and Chronorisk

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Monitoring chronic headache and medication-overuse headache prevalence in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic delay of cluster headache: A cohort study from the Danish Cluster Headache Survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Medication-overuse headache: The effect of a patient educational programme-A randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background The DoloTest is a newer health-related quality of life (HRQoL) monitoring instrument for pain, not yet validated for headache. Aims To examine the usefulness of the DoloTest in a specialized headache center. Methods The sample consisted of patients referred to psychologists from the Danish Headache Center (DHC) for whom the test was carried out at start of, end of, and 6 months after treatment. Points on eight scales of the test were measured (values ranged from 0 to 100), then totaled (0 to 800). Scores were analyzed using Wilcoxon Signed Ranks test. The correlation between headache days and DoloTest scores were computed using linear regression adjusted for age. Qualitative feedback on usefulness of the test were gathered from psychologists. Results Of 135 patients included, 105 completed treatment. On average, headache days decreased from 22 days per month at start of treatment (SD 9.0, median 29) to 18 days at end of treatment (SD 10.8, median 19) (p<0.001). At end of treatment, DoloTest scores improved for pain (p=0.015) and reduced energy and strength (p=0.034). At 6 months' follow-up, total scores improved (p=0.034), as well as component scores for pain (p=0.010), problems with strenuous activity (p=0.045) and reduced energy and strength (p=0.012). Correlation between reduced headache days and improved DoloTest scores was 0.303 (p=0.028). Psychologists found the test useful in monitoring and evaluating patients. Conclusions The DoloTest was useful for psychoeducation and for monitoring the effect of headache treatment. Implications The DoloTest is a potential HRQoL monitoring instrument for headache patients. We recommend further validation studies.

Original languageEnglish
JournalScandinavian Journal of Pain
Volume18
Issue number3
Pages (from-to)431-439
Number of pages9
ISSN1877-8860
DOIs
Publication statusPublished - 2018

ID: 56703281